An open-label study to evaluate contraceptive efficacy and safety of the transdermal contraceptive system of norelgestromin and ethinyl estradiol

Trial Profile

An open-label study to evaluate contraceptive efficacy and safety of the transdermal contraceptive system of norelgestromin and ethinyl estradiol

Completed
Phase of Trial: Phase IV

Latest Information Update: 23 Oct 2007

At a glance

  • Drugs Ethinylestradiol/norelgestromin (Primary)
  • Indications Pregnancy
  • Focus Therapeutic Use
  • Sponsors Janssen-Cilag
  • Most Recent Events

    • 23 Oct 2007 The expected completion date for this trial is now 1 Dec 2004.
    • 22 Oct 2007 Status changed from in progress to completed.
    • 25 Oct 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top